Nifty
:
24631.30
Sensex
:
80597.66
11.95 (0.05%)
57.75 (0.07%)
Nifty
Sensex
:
:
24631.30
80597.66
11.95 (0.05%)
57.75 (0.07%)

Sudarshan Pharma Industries Ltd.

Pharmaceuticals & Drugs

Rating :
66/99

BSE: 543828 | NSE: Not Listed

NSE BSE
31.06
14-Aug-2025
  • Open
  • High
  • Low
  • Previous Close
  •  30.84
  •  31.49
  •  30.5
  •  30.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  336000
  •  10454440
  •  31.49
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 747.49
  • 47.08
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 917.67
  • N/A
  • 5.86

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 57.39%
  • 4.48%
  • 17.13%
  • FII
  • DII
  • Others
  • 19.49%
  • 0.05%
  • 1.46%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.50
  • 21.17
  • 3.06

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 60.96
  • 41.01
  • 22.13

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 67.75
  • 42.97
  • 31.34

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
145.26
99.20
46.43%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Expenses
134.22
97.12
38.20%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBITDA
11.04
2.08
430.77%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
EBIDTM
7.60%
2.09%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
1.21
0.98
23.47%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
5.96
3.94
51.27%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Depreciation
0.88
0.67
31.34%
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PBT
5.41
-1.55
-
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
Tax
1.45
-0.34
-
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
3.96
-1.21
-
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PATM
2.73%
-1.22%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.17
-0.01
-
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
-
505.05
463.54
461.33
357.09
193.35
Net Sales Growth
-
8.95%
0.48%
29.19%
84.69%
 
Cost Of Goods Sold
-
436.75
422.94
430.72
335.10
177.59
Gross Profit
-
68.30
40.60
30.62
21.99
15.76
GP Margin
-
13.52%
8.76%
6.64%
6.16%
8.15%
Total Expenditure
-
465.13
440.73
446.64
346.18
186.19
Power & Fuel Cost
-
0.13
0.08
0.04
0.00
0.00
% Of Sales
-
0.03%
0.02%
0.01%
0%
0%
Employee Cost
-
3.45
2.68
2.08
1.68
1.38
% Of Sales
-
0.68%
0.58%
0.45%
0.47%
0.71%
Manufacturing Exp.
-
7.27
3.57
4.79
2.80
1.70
% Of Sales
-
1.44%
0.77%
1.04%
0.78%
0.88%
General & Admin Exp.
-
9.60
5.57
3.93
2.75
2.01
% Of Sales
-
1.90%
1.20%
0.85%
0.77%
1.04%
Selling & Distn. Exp.
-
7.51
5.78
4.66
3.75
3.50
% Of Sales
-
1.49%
1.25%
1.01%
1.05%
1.81%
Miscellaneous Exp.
-
0.42
0.12
0.44
0.10
0.00
% Of Sales
-
0.08%
0.03%
0.10%
0.03%
0%
EBITDA
-
39.92
22.81
14.69
10.91
7.16
EBITDA Margin
-
7.90%
4.92%
3.18%
3.06%
3.70%
Other Income
-
2.52
2.61
1.12
0.46
0.38
Interest
-
15.77
8.94
5.40
3.38
3.23
Depreciation
-
2.22
1.24
0.91
0.87
0.74
PBT
-
24.45
15.23
9.50
7.14
3.57
Tax
-
5.68
3.77
2.46
1.89
0.90
Tax Rate
-
26.26%
24.75%
25.89%
26.47%
25.21%
PAT
-
15.95
11.46
7.04
5.25
2.67
PAT before Minority Interest
-
15.95
11.46
7.04
5.25
2.67
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
3.16%
2.47%
1.53%
1.47%
1.38%
PAT Growth
-
39.18%
62.78%
34.10%
96.63%
 
EPS
-
0.66
0.48
0.29
0.22
0.11

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
131.48
111.71
100.97
29.78
22.51
Share Capital
24.07
24.07
24.07
9.75
9.55
Total Reserves
103.59
87.64
76.91
20.03
12.96
Non-Current Liabilities
11.23
10.93
13.03
5.12
5.48
Secured Loans
9.91
9.06
11.78
4.08
2.82
Unsecured Loans
0.55
1.43
1.01
0.86
2.50
Long Term Provisions
0.49
0.42
0.06
0.04
0.03
Current Liabilities
259.69
160.49
118.48
102.62
71.22
Trade Payables
91.83
56.72
91.89
73.75
44.22
Other Current Liabilities
5.82
10.48
7.53
4.89
5.34
Short Term Borrowings
156.59
90.56
18.35
23.59
21.38
Short Term Provisions
5.45
2.74
0.71
0.39
0.28
Total Liabilities
402.40
283.13
232.48
137.52
99.26
Net Block
23.87
25.50
19.89
6.47
6.21
Gross Block
29.92
29.33
22.45
8.49
7.64
Accumulated Depreciation
6.05
3.83
2.56
2.03
1.42
Non Current Assets
67.56
45.91
33.86
7.94
11.62
Capital Work in Progress
6.04
1.88
0.01
0.54
0.00
Non Current Investment
28.84
12.34
12.34
0.00
0.00
Long Term Loans & Adv.
4.56
1.83
1.62
0.94
5.40
Other Non Current Assets
4.25
4.35
0.00
0.00
0.00
Current Assets
334.85
237.22
198.62
129.58
87.64
Current Investments
1.50
1.50
0.00
0.00
0.00
Inventories
140.48
85.74
74.57
46.87
23.96
Sundry Debtors
160.16
122.55
81.51
73.48
60.39
Cash & Bank
0.55
0.14
11.72
0.24
1.25
Other Current Assets
32.15
9.50
1.09
0.45
2.03
Short Term Loans & Adv.
29.18
17.79
29.74
8.55
1.60
Net Current Assets
75.15
76.73
80.14
26.96
16.42
Total Assets
402.41
283.13
232.48
137.52
99.26

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
35.22
7.75
-28.79
-3.82
2.77
PBT
21.63
15.23
9.50
7.14
3.57
Adjustment
20.01
9.40
5.82
4.05
3.94
Changes in Working Capital
-3.48
-14.72
-42.00
-13.24
-3.91
Cash after chg. in Working capital
38.16
9.91
-26.69
-2.05
3.61
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.94
-2.15
-2.11
-1.77
-0.84
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-20.41
-7.23
-25.65
-1.46
-1.29
Net Fixed Assets
-4.70
-3.78
-13.43
-1.39
Net Investments
-16.57
-4.50
-12.34
-0.01
Others
0.86
1.05
0.12
-0.06
Cash from Financing Activity
-14.45
-12.10
65.93
4.26
-1.49
Net Cash Inflow / Outflow
0.37
-11.58
11.48
-1.02
-0.01
Opening Cash & Equivalents
0.14
11.72
0.24
1.25
1.27
Closing Cash & Equivalent
0.55
0.14
11.72
0.24
1.25

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
5.30
4.64
4.20
30.54
23.58
ROA
4.65%
4.44%
3.80%
4.43%
2.69%
ROE
13.33%
10.77%
10.76%
20.08%
11.87%
ROCE
14.42%
13.75%
15.25%
18.67%
13.01%
Fixed Asset Turnover
17.05
17.90
29.82
44.28
25.32
Receivable days
102.16
80.34
61.31
68.42
114.01
Inventory Days
81.75
63.12
48.04
36.20
45.24
Payable days
62.07
64.12
70.18
64.25
90.88
Cash Conversion Cycle
121.83
79.33
39.17
40.37
68.37
Total Debt/Equity
1.34
0.94
0.34
1.03
1.32
Interest Cover
2.37
2.70
2.76
3.11
2.11

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Sudarshan Pharma Ind - Quarterly Results
    14th Aug 2025, 19:42 PM

    Read More
  • Sudarshan Pharma Industries gets nod to incorporate wholly-owned subsidiary in Canada
    20th Jun 2025, 10:41 AM

    The incorporation of the proposed subsidiary company will allow the company to establish a place of business in the Canada

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.